Regeneron Pharma (REGN) PT Raised to $950 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| Regeneron (NASDAQ: REGN) | Delayed: 925.99 +107.22 (13.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $818.77 | 52 Week High | $592.36 | |||
| Open | $869.43 | 52 Week Low | $325.35 | |||
| Day High | $935.35 | P/E | 243.04 | |||
| Day Low | $839.08 | EPS | $3.81 | |||
| Volume | 665,803 | |||||
